NCT04282018 2026-02-20Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and TislelizumabBeOne MedicinesPhase 1/2 Completed97 enrolled 43 charts
NCT06563596 2026-02-19Epco, Zanu, Ritux for R/R FL or MZLDana-Farber Cancer InstitutePhase 2 Recruiting45 enrolled